Michael D. Farwell, MD
Radiology
Headshot of Michael D. Farwell, MD

Michael D. Farwell, MD

Radiology
Accepting new patients
Sees patients age 18 and up
Headshot of Michael D. Farwell, MD
Penn Medicine Provider

About me

  • Division Chief, Nuclear Medicine Imaging and Therapy, Department of Radiology
  • Associate Professor of Radiology at the Hospital of the University of Pennsylvania

My education and training

  • Columbia UniversityMedical School
  • Mount Sinai MorningsideResidency
  • NewYork-Presbyterian/Columbia University Medical CenterResidency
  • NewYork-Presbyterian/Columbia University Medical CenterFellowship

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Penn Medicine hospital privileges

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Farwell is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Postow MA, Zang PD, Pal SK, Mauguen A, Farwell M, Gordon M, Hays D, Wong JYC, Chen D, Ulaner GA, Esposito G, McConathy J, Graham MM, Shields AF, Van den Abbeele AD, Butler MO, Thomas JS, Twardowski P, Narang J, Singh AP, Dey A, Maresca KP, Keliher E, Liu F, Potdevin G, Schmidt G, Le W, Wilson I, Mascioni A, Jia F, Korn R, Ferris MR, Schmiedehausen K, Pandit-Taskar N, Margolin KA CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study. , J Immunother Cancer., 14(3): 2026,e012208


de Souza Carvalho G, Cunha de Sousa Martins CL, Wang K, Farwell MD, Salama AKS Beyond Routine Surveillance Imaging for Melanoma: Emerging Technologies for Detecting Early Recurrence and Guiding Clinical Management. , Am Soc Clin Oncol Educ Book., 46(3): 2026,e520544


Weeks JK, Pantel AR, Gitto SB, Liu F, Schubert EK, Pryma DA, Farwell MD, Mankoff DA, Mach RH, Simpkins F, Lin LL [18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status. , J Nucl Med., 66(1): 2025,34-39


Gupta PK, Li LZ, Singh DK, Nova S, Arias-Mendoza F, Orlovskiy S, Chawla S, Nelson DS, Farwell MD, Nath K MRS and Optical Imaging Studies of Therapeutic Response to Combination Therapy Targeting BRAF/MEK in Murine Melanomas. , Acad Radiol., S1076-6332(25)00090-X: 2025,Epub ahead of print


Sarkar S, Pham JM, Edwards KJ, Sharma N, Xu K, King AP, Del Castillo AF, Farwell MD, Pryma DA, Schuster SJ, Sellmyer MA A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points. , EJNMMI Res., 15(1): 2025,26


Babazada H, Martorano P, Lee H, Geng S, Batra V, Maris JM, Pryma DA, Gitto SB, Farwell MD PARP1-targeted alpha therapy enhances target expression. , EJNMMI Res., 15(1): 2025,63


Anderson TM, Chang BH, Huang AC, Xu X, Yoon D, Shang CG, Mick R, Schubert E, McGettigan S, Kreider K, Xu W, Wherry EJ, Schuchter LM, Amaravadi RK, Mitchell TC, Farwell MD FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. , Clin Cancer Res., 30(9): 2024,1758-1767


McGale JP, Chen DL, Trebeschi S, Farwell MD, Wu AM, Cutler CS, Schwartz LH, Dercle L Artificial intelligence in immunotherapy PET/SPECT imaging. , Eur Radiol., 34(9): 2024,5829-5841


Hartmann K, Gillman JA, Lazor JW, Ware JB, Weeks JK, Nasrallah IM, Farwell MD, Pantel AR 68Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis. , Clin Nucl Med., 49(1): 2024,9-15


Vidula MK, Selvaraj S, Rojulpote C, Bhattaru A, Kc W, Hansbury M, Schubert E, Clancy CB, Rossman M, Goldberg LR, Farwell M, Pryma D, Bravo PE Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis. , Circ Cardiovasc Imaging., 17(8): 2024,e016774